Evaluating zuranolone: Discrepancies and insights from multiple systematic reviews and meta-analyses on major depression and postpartum depression treatment
Zuranolone, a novel neuroactive steroid and positive allosteric modulator of γ-aminobutyric acid type A (GABAA) receptors, has been explored for its potential in treating major depressive disorder (MDD) and postpartum depression (PPD). This review compiles findings from multiple systematic reviews a...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-12-01
|
| Serier: | Brain Disorders |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S266645932500112X |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
